05/11/2023
Tafamidis is an oral medication for treating cardiomyopathy and peripheral neuropathy due to transthyretin amyloidosis (ATTR). It is a transthyretin stabilizer and has been shown to reduce disease progression and mortality significantly.
ATTR is a rare genetic disorder that can cause a range of symptoms, including nerve damage, heart problems, and difficulty swallowing. Until recently, there were no effective treatments for this devastating disease. But with the introduction of Tafamidis, patients now have a real chance at improving their quality of life.
Tafamidis has been shown to slow the progression of ATTR and improve patients' ability to perform everyday activities. If you or a loved one has been diagnosed with ATTR, don't wait to talk to your doctor about whether Tafamidis could be right for you.
Chats for purchase: +13239253331
future!
